Despite the setback, AstraZeneca maintains that its drug does not infringe on the patents and argues that patents themselves are invalid. Read Next: Pfizer Agrees To Settle Over 10,000 Lawsuits ...
AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...
Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging customers for a decade when they bought generic drugs through private ...
The lawsuits against AstraZeneca Families of individuals affected by adverse vaccine reactions continue to pursue legal recourse against AstraZeneca and the Serum Institute of India. Venugopalan ...
Attorney General Phil Weiser announced the $10 million settlement with Heritage Pharmaceuticals and $39.1 million settlement ...
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...
Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was ...
Nashville Electric Service has settled lawsuits brought by three Black employees ... order is in place preventing him from discussing his settlement.
Former City Councilor Steven Farber received a $50,000 payout in April 2023 in a settlement agreement for an open records lawsuit in which he alleged the city had stonewalled his requests for ...